Pharmafile Logo
Pharmafocus logo
Advanced Search

Stem cells and patents: a potent mix

June 10, 2010
Research and Development Stem cells, stem cell

In recent years, there has been much debate about whether or not the use of stem cells in medical research …

Feature
Genzyme

Genzyme and Icahn agree compromise deal

June 10, 2010
Research and Development, Sales and Marketing Genzyme

Carl Icahn has won his battle with Genzyme to have his associates given a place on the company’s board.The US …

News

Study re-opens debate about pharma chemicals in wastewater

June 10, 2010
Manufacturing and Production manufacturing, manufacturing compliance

Wastewater from pharmaceutical manufacturing facilities is a major source of drug compounds in the environment, according to a new study …

News
Blog footer

Digital Pharma: Online clinical collaboration

June 10, 2010
Research and Development biomarkers, digital doctors, digital pharma research, proteomic

A new online educational resource will offer researchers across the medical community access to peer-reviewed information on biomarkers. The portal …

News

NICE rejects GSK’s Revolade

June 10, 2010
Sales and Marketing ITP, NICE, Revolade

NICE has rejected GlaxoSmithKline’s Revolade saying in draft guidance that the blood disorder drug’s benefits were unclear. The watchdog assessed …

News

Pfizer appoints neuroscience research head

June 10, 2010
Research and Development Pfizer, appointment, research and development

Pfizer has appointed Dr Michael Ehlers chief scientific officer for neuroscience research. Dr Ehlers most recently served as the George …

Appointment
TyverbWeb

NICE says no to GSK breast cancer drug

June 10, 2010
Sales and Marketing NICE, Tyverb

NICE has issued final draft guidance restricting use of GlaxoSmithKline’s breast cancer drug Tyverb to clinical trials, citing high cost …

News

‘Stellar’ performance from targeted lung cancer drug

June 9, 2010
Research and Development Pfizer, biomarkers, crizotinib

A new targeted treatment for non small cell lung cancer has produced spectacular results in a sub-group of patients. Pfizer’s …

News

Nerve gas antidote completes phase I trial

June 9, 2010
Research and Development Protalix, biodefence

Israeli biotech firm Protalix has completed a phase I clinical trial for its intravenous nerve gas antidote. The drug is …

News

Eisai’s breast cancer drug impresses at ASCO

June 9, 2010
Research and Development ASCO, Eisai, Xeloda, eribulin

A new cancer drug developed by Japanese pharma company Eisai has shown promise in increasing overall survival rates in heavily …

News

Lansley calls for “cultural shift in the NHS”

June 9, 2010
NHS, government, king's fund

In his first speech as health secretary Andrew Lansley has called for a “cultural shift in the NHS”, moving away …

News

Tim Wragg to head up Millward Brown in Europe

June 9, 2010
Medical Communications Millward Brown, appointment, medical communications

Research company Millward Brown has appointed Tim Wragg to the newly-created position of chief executive, Europe. In his new position …

Appointment

Dr Laurent Audoly joins Pieris

June 9, 2010
Research and Development Pieris, appointment, research and development

French biotech company Pieris has appointed Dr Laurent Audoly as chief scientific officer. Dr Audoly was most recently biologics research …

Appointment

Talking Point: Crisis Management

June 9, 2010
Medical Communications Red Door, Talking Point

It is surprising to me how many companies and people in business are under-prepared and under-rehearsed for a crisis. On …

Feature

EMA sees fewer quality defects in ’09 inspections

June 9, 2010
Manufacturing and Production API, EMA, manufacturing, manufacturing compliance

The European Medicines Agency carried out 175 inspections of manufacturing facilities in 2009, a little lower than its target, according …

News

Eurocom expands international network

June 9, 2010
Medical Communications Eurocom, PBK

Eurocom Healthcare Communications has expanded its international communications network, adding leading Austrian agency PBK Ideennrerich to the fold. Eurocom said …

News

Merck Serono resubmits oral MS therapy to FDA

June 8, 2010
Research and Development Cladribine, MS, Merck KGaA

Merck Serono has re-submitted its oral multiple sclerosis therapy cladribine to US regulators. Merck Serono, a Swiss division of Merck …

News

Sanofi to develop monoclonal antibody jabs

June 8, 2010
Research and Development Sanofi Pasteur, Vivalis, vaccines

Sanofi-Aventis is to develop a range of monoclonal antibody for use against infectious diseases. The French pharma company’s vaccines arm …

News

EU regulators to assess potential lupus breakthrough drug

June 8, 2010
Sales and Marketing Benlysta, Human Genome Sciences, Lupus

GlaxoSmithKline and Human Genome Sciences have submitted a marketing application to the European Medicines Agency for their new lupus drug. …

News

CME Spotlight: Power to the people

June 8, 2010
Medical Communications, Sales and Marketing CME Spotlight, transparency

The UK general election is now over and as we stayed up to watch the count, or woke on the …

Feature
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026